Arch Biopartners Inc
XTSX:ARCH
Arch Biopartners Inc
XTSX:ARCH
Price:
0.73
CAD
Market Closed
Market Cap:
CA$48.9m
Relative Value
The Relative Value of one
ARCH
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 0.73 CAD,
Arch Biopartners Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ARCH Relative Value
HIDDEN
Multiples Across Competitors
ARCH Competitors Multiples
Arch Biopartners Inc Competitors
Arch Biopartners Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Arch Biopartners Inc
XTSX:ARCH
|
48.9m CAD | 309.1 | -18.1 | -21.1 | -21.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
174.7B USD | 3.9 | 26.1 | 18.4 | 24.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.4B USD | 5.4 | 36.6 | 18.7 | 27.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.2B CHF | 5.1 | 35 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.9B CNY | 5.9 | 17.4 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.5B USD | 4.5 | 24.5 | 19.2 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.1B USD | 8.9 | 43.7 | 28.2 | 35.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.9B USD | 5.9 | 27.5 | 20.5 | 22.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
